A University of Missouri-led discovery could pave the way for improved diagnosis and treatment of unexplained movement ...
Novartis plans to acquire Avidity Biosciences to add RNA therapeutics to its neuroscience biz to target rare genetic ...
An international research team, led by Shinghua Ding at the University of Missouri, has identified a previously unknown ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback